A detailed history of Baker Bros. Advisors LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 2,497,526 shares of TSVT stock, worth $7.47 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,497,526
Previous 2,497,526 -0.0%
Holding current value
$7.47 Million
Previous $9.62 Million 22.6%
% of portfolio
0.13%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$9.21 - $14.98 $4 Million - $6.51 Million
434,782 Added 21.08%
2,497,526 $25.5 Million
Q1 2022

May 16, 2022

BUY
$11.67 - $26.72 $14.3 Million - $32.9 Million
1,229,508 Added 147.56%
2,062,744 $35.2 Million
Q4 2021

Feb 14, 2022

BUY
$13.77 - $42.56 $11.5 Million - $35.5 Million
833,236 New
833,236 $21.4 Million

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.